- AT&T Inc.’s (NYSE:T) shares increased 0.6% after the company announced that there will be fewer commercials, personalized programming and smaller channel bundles following its acquisition of Time Warner
- Shares of Foundation Medicine, Inc. (NASDAQ:FMI) surged 28.5% on news that Swiss drug behemoth Roche was buying out the company for $2.4 billion
- Cotiviti Holdings, Inc.’s (NYSE:T) shares increased 10.3% after Verscend Technologies Inc agreed to buy the company for $4.9 billion
- Shares of Sarepta Therapeutics, Inc. (NYSE:T) rose 36.8% after the company announced positive results from Phase 1/2 test on its microdystrophin gene therapy for Duchenne muscular dystrophy, or DMD
Foundation Medicine, Inc. (FMI): Free Stock Analysis Report
AT&T Inc. (T): Free Stock Analysis Report
Sarepta Therapeutics, Inc. (SRPT): Free Stock Analysis Report
Cotiviti Holdings, Inc. (COTV): Free Stock Analysis Report
Original post
Zacks Investment Research